BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 38436365)

  • 1. Antiplatelet therapy after coronary artery bypass surgery: five year follow-up of randomised DACAB trial.
    Zhu Y; Zhang W; Dimagli A; Han L; Cheng Z; Mei J; Chen X; Wang X; Zhou Y; Xue Q; Hu J; Tang M; Wang R; Song Y; Kang L; Redfors B; Gaudino M; Zhao Q
    BMJ; 2024 Jun; 385():e075707. PubMed ID: 38862179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive value of multiple electrode platelet aggregometry for postoperative bleeding complications in patients undergoing coronary artery bypass graft surgery.
    Woźniak S; Woźniak K; Hryniewiecki T; Kruk M; Różański J; Kuśmierczyk M
    Kardiochir Torakochirurgia Pol; 2016 Mar; 13(1):3-9. PubMed ID: 27212971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet Resistance in Coronary Artery Bypass Grafting: A Systematic Review.
    Thet MS; Khosravi A; Egbulonu S; Oo AY
    Surg Res Pract; 2024; 2024():1807241. PubMed ID: 38910604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bentracimab for Ticagrelor Reversal in Patients Undergoing Urgent Surgery.
    Bhatt DL; Pollack CV; Mazer CD; Angiolillo DJ; Steg PG; James SK; Weitz JI; Ramnath R; Arnold SE; Mays MC; Umstead BR; White B; Hickey LL; Jennings LK; Curry BJ; Lee JS; Verma S
    NEJM Evid; 2022 Mar; 1(3):EVIDoa2100047. PubMed ID: 38319214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54.
    Parker WA; Storey RF
    Heart; 2016 May; 102(10):783-9. PubMed ID: 26857211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Antiplatelet Therapy After Acute Coronary Syndrome: A Review.
    Kamran H; Jneid H; Kayani WT; Virani SS; Levine GN; Nambi V; Khalid U
    JAMA; 2021 Apr; 325(15):1545-1555. PubMed ID: 33877270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-month DAPT with ticagrelor and aspirin for patients undergoing coronary artery bypass grafting: rationale and design of the randomised, multicentre, double-blind, placebo-controlled ODIN trial.
    Sandner S; Gaudino M; Redfors B; Angiolillo DJ; Ben-Yehuda O; Bhatt DL; Fremes SE; Lamy A; Marano R; Mehran R; Pocock S; Rao SV; Spertus JA; Weinsaft JW; Wells G; Ruel M
    EuroIntervention; 2024 Mar; 20(5):e322-e328. PubMed ID: 38436365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial.
    Ge Z; Kan J; Gao X; Raza A; Zhang JJ; Mohydin BS; Gao F; Shao Y; Wang Y; Zeng H; Li F; Khan HS; Mengal N; Cong H; Wang M; Chen L; Wei Y; Chen F; Stone GW; Chen SL;
    Lancet; 2024 May; 403(10439):1866-1878. PubMed ID: 38599220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis.
    Sandner S; Redfors B; Angiolillo DJ; Audisio K; Fremes SE; Janssen PWA; Kulik A; Mehran R; Peper J; Ruel M; Saw J; Soletti GJ; Starovoytov A; Ten Berg JM; Willemsen LM; Zhao Q; Zhu Y; Gaudino M
    JAMA; 2022 Aug; 328(6):554-562. PubMed ID: 35943473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled trial investigating the effect of ticagrelor on saphenous vein graft patency in patients undergoing coronary artery bypass grafting surgery-Rationale and design of the POPular CABG trial.
    Willemsen LM; Janssen PWA; Hackeng CM; Kelder JC; Tijssen JGP; van Straten AHM; Soliman-Hamad MA; Deneer VHM; Daeter EJ; Sonker U; Klein P; Ten Berg JM
    Am Heart J; 2020 Feb; 220():237-245. PubMed ID: 31884246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study.
    Sardella G; Beerkens FJ; Dangas G; Cao D; Baber U; Sartori S; Cohen DJ; Briguori C; Gil R; Nicolas J; Zhang Z; Dudek D; Kunadian V; Kornowski R; Weisz G; Claessen B; Marx S; Escaned J; Huber K; Collier T; Moliterno DJ; Ohman EM; Krucoff MW; Kastrati A; Steg PG; Angiolillo DJ; Mehta S; Shlofmitz R; Sharma S; Pocock S; Gibson CM; Mehran R
    EuroIntervention; 2022 Dec; 18(11):e897-e909. PubMed ID: 35979636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.
    Ohman EM; Roe MT; Steg PG; James SK; Povsic TJ; White J; Rockhold F; Plotnikov A; Mundl H; Strony J; Sun X; Husted S; Tendera M; Montalescot G; Bahit MC; Ardissino D; Bueno H; Claeys MJ; Nicolau JC; Cornel JH; Goto S; Kiss RG; Güray Ü; Park DW; Bode C; Welsh RC; Gibson CM
    Lancet; 2017 May; 389(10081):1799-1808. PubMed ID: 28325638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graft Failure After Coronary Artery Bypass Grafting and Its Association With Patient Characteristics and Clinical Events: A Pooled Individual Patient Data Analysis of Clinical Trials With Imaging Follow-Up.
    Gaudino M; Sandner S; An KR; Dimagli A; Di Franco A; Audisio K; Harik L; Perezgrovas-Olaria R; Soletti G; Fremes SE; Hare DL; Kulik A; Lamy A; Peper J; Ruel M; Ten Berg JM; Willemsen LM; Zhao Q; Wojdyla DM; Bhatt DL; Alexander JH; Redfors B
    Circulation; 2023 Oct; 148(17):1305-1315. PubMed ID: 37417248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft thrombosis after coronary artery bypass surgery and current practice for prevention.
    Harik L; Perezgrovas-Olaria R; Soletti G; Dimagli A; Alzghari T; An KR; Cancelli G; Gaudino M; Sandner S
    Front Cardiovasc Med; 2023; 10():1125126. PubMed ID: 36970352
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.